1. Home
  2. PRAX vs FLS Comparison

PRAX vs FLS Comparison

Compare PRAX & FLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$337.29

Market Cap

9.0B

Sector

Health Care

ML Signal

HOLD

Logo Flowserve Corporation

FLS

Flowserve Corporation

HOLD

Current Price

$70.20

Market Cap

9.9B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
FLS
Founded
2015
1790
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
9.9B
IPO Year
2020
2006

Fundamental Metrics

Financial Performance
Metric
PRAX
FLS
Price
$337.29
$70.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
11
Target Price
$572.13
$86.00
AVG Volume (30 Days)
326.2K
2.5M
Earning Date
05-08-2026
04-29-2026
Dividend Yield
N/A
1.04%
EPS Growth
N/A
23.36
EPS
N/A
0.64
Revenue
N/A
N/A
Revenue This Year
N/A
$6.80
Revenue Next Year
$7,758.26
$6.22
P/E Ratio
N/A
$111.63
Revenue Growth
N/A
N/A
52 Week Low
$34.89
$45.63
52 Week High
$354.87
$92.41

Technical Indicators

Market Signals
Indicator
PRAX
FLS
Relative Strength Index (RSI) 55.91 35.50
Support Level $282.49 $69.50
Resistance Level $353.83 $74.71
Average True Range (ATR) 18.75 3.75
MACD -0.96 -1.43
Stochastic Oscillator 69.67 1.76

Price Performance

Historical Comparison
PRAX
FLS

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

Share on Social Networks: